Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Microdosing: a new approach to clinical drug development

Human microdosing - or Phase 0 trials - offers a way of developing drugs in a faster, more cost-effective and ethical way than ever before.

Jeremy Hague, Xceleron Ltd (June 2004)

Keywords: human microdosing, phase 0 trials, drug development, clinical trials, pharmacokinetics, pharmacodynamics, metabolism, AMS, PET, EMEA, microdosing,

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |